NO20014380D0 - 6-O-Substituerte makrolider som har antibakteriell aktivitet - Google Patents

6-O-Substituerte makrolider som har antibakteriell aktivitet

Info

Publication number
NO20014380D0
NO20014380D0 NO20014380A NO20014380A NO20014380D0 NO 20014380 D0 NO20014380 D0 NO 20014380D0 NO 20014380 A NO20014380 A NO 20014380A NO 20014380 A NO20014380 A NO 20014380A NO 20014380 D0 NO20014380 D0 NO 20014380D0
Authority
NO
Norway
Prior art keywords
antibacterial activity
macrolides
group
optionally substituted
proviso
Prior art date
Application number
NO20014380A
Other languages
English (en)
Norwegian (no)
Other versions
NO20014380L (no
Inventor
Yat Sun Or
Richard F Clark
Zhenkun Ma
Michael J Rupp
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20014380D0 publication Critical patent/NO20014380D0/no
Publication of NO20014380L publication Critical patent/NO20014380L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20014380A 1999-03-15 2001-09-10 6-O-Substituerte makrolider som har antibakteriell aktivitet NO20014380L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27049799A 1999-03-15 1999-03-15
PCT/US2000/006033 WO2000055168A1 (en) 1999-03-15 2000-03-08 6-o-substituted macrolides having antibacterial activity

Publications (2)

Publication Number Publication Date
NO20014380D0 true NO20014380D0 (no) 2001-09-10
NO20014380L NO20014380L (no) 2001-09-10

Family

ID=23031548

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014380A NO20014380L (no) 1999-03-15 2001-09-10 6-O-Substituerte makrolider som har antibakteriell aktivitet

Country Status (25)

Country Link
EP (1) EP1161438B1 (ja)
JP (1) JP2002539217A (ja)
KR (1) KR20020008127A (ja)
CN (1) CN1343215A (ja)
AT (1) ATE266036T1 (ja)
AU (1) AU3517700A (ja)
BG (1) BG105865A (ja)
BR (1) BR0008731A (ja)
CA (1) CA2367431C (ja)
CO (1) CO5271742A1 (ja)
CZ (1) CZ20013223A3 (ja)
DE (1) DE60010442T2 (ja)
DK (1) DK1161438T3 (ja)
ES (1) ES2222189T3 (ja)
HK (1) HK1044157A1 (ja)
HU (1) HUP0201067A3 (ja)
IL (1) IL144542A0 (ja)
NO (1) NO20014380L (ja)
NZ (1) NZ513206A (ja)
PL (1) PL350650A1 (ja)
PT (1) PT1161438E (ja)
SK (1) SK13162001A3 (ja)
TR (1) TR200102522T2 (ja)
WO (1) WO2000055168A1 (ja)
ZA (1) ZA200106181B (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE340183T1 (de) * 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
GB0031312D0 (en) 2000-12-21 2001-02-07 Glaxo Group Ltd Macrolides
TWI246515B (en) * 2001-05-30 2006-01-01 Abbott Lab An arylation method for the functionalization of O-allyl erythromycin derivatives
WO2003068791A2 (en) * 2002-02-13 2003-08-21 Abbott Laboratories Macrolides with activity against methicillin-resistant staphylococcus aureus
TWI328009B (en) 2003-05-21 2010-08-01 Glaxo Group Ltd Quinoline derivatives as phosphodiesterase inhibitors
KR101431279B1 (ko) 2005-07-29 2014-08-20 리스버로직스 코퍼레이션 복합 질환의 예방 및 치료용 약학적 조성물 및 삽입가능한의료 장치에 의한 이의 전달
EP2086970B1 (en) * 2006-08-24 2014-02-26 Novartis AG 2-(pyrazin-2-yl)-thiazole and 2-(1h pyrazol-3-yl)-thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders
RU2009114857A (ru) 2006-09-22 2010-10-27 Новартис АГ (CH) Гетероциклические органические соединения
EA200900820A1 (ru) 2006-12-20 2010-02-26 Новартис Аг 2-замещенные 5-членные гетероциклы в качестве ингибиторов стеароил-соа-десатуразы (ссд)
MX2009008099A (es) 2007-02-01 2009-12-14 Resverlogix Corp Compuestos para la prevencion y tratamiento de enfermedades cardiovasculares.
JP5602728B2 (ja) 2008-06-26 2014-10-08 レスバーロジックス コーポレイション キナゾリノン誘導体の製造方法
EP2382194B1 (en) 2009-01-08 2014-03-12 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
WO2010106436A2 (en) 2009-03-18 2010-09-23 Resverlogix Corp. Novel anti-inflammatory agents
SI2421533T1 (sl) 2009-04-22 2019-01-31 Resverlogix Corp. Nova protivnetna sredstva
DK2773354T3 (da) 2011-11-01 2019-08-05 Resverlogix Corp Oralformuleringer med øjeblikkelig frigivelse for substituerede quinazolinoner
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
CA2895905A1 (en) 2012-12-21 2014-06-26 Zenith Epigenetics Corp. Novel heterocyclic compounds as bromodomain inhibitors
CN104650166B (zh) * 2014-11-17 2017-12-05 广东东阳光药业有限公司 一种大环内酯的制备方法
EP3268007B1 (en) 2015-03-13 2022-11-09 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1291351B1 (en) * 1996-09-04 2005-07-13 Abbott Laboratories 6-0 substituted ketolides having antibacterial activity
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців

Also Published As

Publication number Publication date
NZ513206A (en) 2004-02-27
DE60010442T2 (de) 2005-05-12
CO5271742A1 (es) 2003-04-30
PL350650A1 (en) 2003-01-27
JP2002539217A (ja) 2002-11-19
EP1161438A1 (en) 2001-12-12
KR20020008127A (ko) 2002-01-29
CN1343215A (zh) 2002-04-03
HK1044157A1 (zh) 2002-10-11
AU3517700A (en) 2000-10-04
CA2367431A1 (en) 2000-09-21
NO20014380L (no) 2001-09-10
ZA200106181B (en) 2002-10-26
DK1161438T3 (da) 2004-08-30
HUP0201067A2 (en) 2002-08-28
EP1161438B1 (en) 2004-05-06
HUP0201067A3 (en) 2004-07-28
BR0008731A (pt) 2002-09-24
ES2222189T3 (es) 2005-02-01
SK13162001A3 (sk) 2001-12-03
CZ20013223A3 (cs) 2002-01-16
TR200102522T2 (tr) 2001-12-21
IL144542A0 (en) 2002-05-23
CA2367431C (en) 2008-06-10
DE60010442D1 (de) 2004-06-09
PT1161438E (pt) 2004-09-30
ATE266036T1 (de) 2004-05-15
BG105865A (en) 2002-05-31
WO2000055168A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
NO20014380L (no) 6-O-Substituerte makrolider som har antibakteriell aktivitet
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
SE9904108D0 (sv) Nya föreningar
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
TR200200436T2 (tr) Yeni makrolit antibiyotikler
ATE161265T1 (de) Derivate von 16-gliedrigen antibiotischen macroliden
DK1037650T3 (da) Præparater til behandling af Staphylococcus aureus-infektioner
WO2002062767A1 (fr) Nouveaux derives de quinazoline
DE69402714D1 (de) Amid-derivate von 16-gliedrige heterocyclen als antibiotische macrolide
ATE223226T1 (de) Azazyklohexapeptid-verbindungen
PT1175429E (pt) Derivados halo de 9-desoxo-9a-aza-9a-homoeritromicina a
WO2001057071A3 (en) Glycopeptide derivatives having antibiotic activity
DE60130009D1 (de) Makrolide
DK1000952T3 (da) Nye 2-halogen-derivater af 5-O-deosaminylerythronolid A, fremgangsmåde til fremstilling deraf samt anvendelse deraf som lægemidler
WO2003068790A3 (en) Macrolide antibacterial compounds
TH77750B (th) อนุพันธ์ไกลโคเปปไทด์ฟอสโฟเนท
MY123217A (en) Glycopeptide derivatives and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application